Carol Schaffer

Asset Lead, Inflammation and Immunology Therapeutics – Pfizer


Carol, an Asset Lead in the Inflammation and Immunology therapeutic area at Pfizer, has 25+ years of Pharma experience where she started in research as a protein biochemist and moved into the Clinical Data Management arena in 2000. She has experience in both Early and Late Phase clinical development, both in project management as well as line management. Her therapeutic areas of experience are in Cardiovascular, Metabolism, Inflammation, Immunology, Infectious Diseases, Rare Diseases and Ophthalmology and she also has expertise in all aspects of outsourcing, including study and project oversight as well as global team leadership and governance. Carol holds both Bachelor’s and Master’s degrees in Biology (specializing in Biotechnology) from William Paterson University.